These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 2786965)

  • 21. Target cell membrane modification and susceptibility to lymphokine-activated killer cell-mediated lysis. II. Sodium periodate has a differential effect on the lysis of human and murine tumor cells.
    Midis GP; Gupta VK; Fabian DF; Lefor AT
    J Surg Res; 1994 Feb; 56(2):146-54. PubMed ID: 8121171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.
    Singer A; Kruisbeek AM; Andrysiak PM
    J Immunol; 1984 May; 132(5):2199-209. PubMed ID: 6201534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NK cells can recognize different forms of class I MHC.
    Su RC; Kung SK; Gariépy J; Barber BH; Miller RG
    J Immunol; 1998 Jul; 161(2):755-66. PubMed ID: 9670952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of total lymphoid irradiation on natural killer cells and cytotoxic and primed T lymphocytes.
    Weiss L; Slavin S
    Isr J Med Sci; 1994 Apr; 30(4):253-9. PubMed ID: 8175324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity of lymphokine-activated killer cells induced by IL-2. Separate lymphoid subpopulations lyse tumor, allogeneic blasts, and modified syngeneic blasts.
    LeFor AT; Eisenthal A; Rosenberg SA
    J Immunol; 1988 Jun; 140(11):4062-9. PubMed ID: 3259603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Meth A sarcoma-derived class I major histocompatibility complex-associated peptides recognized by a specific CD8+ cytotoxic T lymphocyte.
    Frassanito MA; Mayordomo JI; DeLeo RM; Storkus WJ; Lotze MT; DeLeo AB
    Cancer Res; 1995 Jan; 55(1):124-8. PubMed ID: 7528638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression.
    Kubota E; Ishikawa H; Saito K
    J Immunol; 1983 Sep; 131(3):1142-8. PubMed ID: 6604089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenic, functional, and molecular genetic studies of human natural killer cells and cytotoxic T lymphocytes not restricted by the major histocompatibility complex.
    Lanier LL; Le AM; Cwirla S; Federspiel N; Phillips JH
    Fed Proc; 1986 Nov; 45(12):2823-8. PubMed ID: 3095151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.
    Yasumura S; Hirabayashi H; Schwartz DR; Toso JF; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1993 Mar; 53(6):1461-8. PubMed ID: 8443824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allogeneic lymphocyte responses to B7-1 expressing human cancer cell lines.
    Dessureault S; Gallinger S
    J Surg Res; 1996 Jul; 64(1):42-8. PubMed ID: 8806472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor activity of T-2 toxin-conjugated monoclonal antibody to murine thymoma.
    Ohtani K; Murakami H; Shibuya O; Kawamura O; Ohi K; Chiba J; Otokawa M; Ueno Y
    Jpn J Exp Med; 1990 Apr; 60(2):57-65. PubMed ID: 2384978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic cell killing by antitumor agents and hyperthermia in cultured cells.
    Mizuno S; Amagai M; Ishida A
    Gan; 1980 Aug; 71(4):471-8. PubMed ID: 6159245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Susceptibility of leukemias with increased antigenicity to immunological lysis].
    Missiroli A; Nicolotti G; Di Padova F; Cattoi C
    Arch Sci Med (Torino); 1976; 133(3):223-8. PubMed ID: 1016557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of human serum albumin with anticancer agents in vitro.
    Takahashi I; Ohnuma T; Kavy S; Bhardwaj S; Holland JF
    Br J Cancer; 1980 Apr; 41(4):602-8. PubMed ID: 7190020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune regulation: a critical link between NK cells and CTLs.
    Kos FJ; Engleman EG
    Immunol Today; 1996 Apr; 17(4):174-6. PubMed ID: 8871349
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute Kidney Injury is Aggravated in Aged Mice by the Exacerbation of Proinflammatory Processes.
    Marquez-Exposito L; Tejedor-Santamaria L; Santos-Sanchez L; Valentijn FA; Cantero-Navarro E; Rayego-Mateos S; Rodrigues-Diez RR; Tejera-Muñoz A; Marchant V; Sanz AB; Ortiz A; Goldschmeding R; Ruiz-Ortega M
    Front Pharmacol; 2021; 12():662020. PubMed ID: 34239439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-institutional randomized clinical study on the comparative effects of intracavital chemotherapy alone versus immunotherapy alone versus immunochemotherapy for malignant effusion.
    Nio Y; Nagami H; Tamura K; Tsubono M; Nio M; Sato M; Kawabata K; Hayashi H; Shiraishi T; Imai S; Tsuchitani T; Mizuta J; Nakagawa M; Fukumoto M
    Br J Cancer; 1999 May; 80(5-6):775-85. PubMed ID: 10360655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunomodulation following chemotherapy.
    Obadina M; Verma U; Hawkins M; Mazumder A
    Breast Cancer Res Treat; 1996; 38(1):41-8. PubMed ID: 8825121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.